首页 > 最新文献

Human Gene最新文献

英文 中文
YES1 c.596C>T (p.Arg199His) and YES1 c.868C>T (p.Glu290Lys) missense polymorphism linked to hematological and reproductive organ cancer: A hidden Markov model (HMM) based approach 基于隐马尔可夫模型(HMM)的YES1 c.596C . >T (p.Arg199His)和YES1 c.868C . >T (p.Glu290Lys)错义多态性与血液学和生殖器官癌相关
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-10-03 DOI: 10.1016/j.humgen.2025.201487
Raushan Kumar Chaudhary , Allen Pinto , Niyas Rehman , Debodipta Das , Rajesh Raju
YES1 is a novel proto-oncogene that has largely gained popularity in oncology over the last few years owing to its pivotal role in tumorigenesis, and drug resistance to various targeted therapy (EGFR, HER2) and cancer chemotherapy, resulting in poor survival outcomes, which has been frequently linked with its amplification rather than the mutation. Thus, this study hypothesizes that cancer development might also be linked with a mutation in YES1, not merely amplification of the gene. In the present study, YES1 gene-associated missense SNPs were retrieved from the dbSNP-NCBI database, which were screened for deleterious/damaging and pathogenicity. The pathogenic SNPs were assessed for their stability and potential to cause cancer. The oncogenic SNPs were further evaluated for its location in the domain, conservation, structural effect, and interactions. Further, YES1 expression in cancer, its hallmark efficiency and mutation in cancer was assessed to support the study findings. A total of 381 SNPs were identified from dbSNP-NCBI of which 7 SNPs were found to be deleterious, damaging and pathogenic by applying six tools. Out of these 7 SNPs, YES1 c.596C > T (p.Arg199His) and YES1 c.868C > T (p.Glu290Lys) were predicted destabilize the protein and associated with blood cancer, and solid cancer like reproductive organ cancer, and gastrointestinal (GI) cancer respectively. Both these oncogenic SNPs occurs in core biologically active conserved domain (SH2 and tyrosine kinase) of YES1 protein thereby influences the protein geometry, electrostatic interaction, impairs the ATP/substrate binding and kinase activity of the protein which might dysregulate the protein-protein interaction and modulate various cancer pathways. Further, its significant expression in cancer (hematologic, reproductive and GI cancer), role in driving invasion/metastasis, and evidence of YES1 mutation profile in cancer cohort strengthen the findings of current study. Thus, R199H and E290K SNPs are the most probable SNPs that should be screened among cancer patients to establish a plausible link which can guide towards the precision therapy to counter the drug resistance and enhance the clinical benefit in upcoming years.
YES1是一种新的原癌基因,由于其在肿瘤发生中的关键作用,以及对各种靶向治疗(EGFR, HER2)和癌症化疗的耐药性,在过去几年中在肿瘤学中得到了很大程度上的普及,导致生存结果较差,这通常与其扩增而不是突变有关。因此,这项研究假设癌症的发展也可能与YES1的突变有关,而不仅仅是基因的扩增。在本研究中,从dbSNP-NCBI数据库中检索YES1基因相关错义snp,并对其进行有害/破坏性和致病性筛选。对致病性snp的稳定性和致癌潜力进行了评估。我们进一步评估了这些致癌snp在结构域的位置、保守性、结构效应和相互作用。此外,我们还评估了YES1在癌症中的表达、其在癌症中的标志效率和突变,以支持研究结果。应用6种工具从dbSNP-NCBI中共鉴定出381个snp,其中7个snp为有害、破坏性和致病性snp。在这7个snp中,预计YES1 c.596C > T (p.a arg199his)和YES1 c.868C > T (p.g glu290lys)会破坏该蛋白的稳定性,并分别与血癌、生殖器官癌和胃肠道(GI)癌等实体癌相关。这两种致癌snp都发生在YES1蛋白的核心生物活性保守结构域(SH2和酪氨酸激酶),从而影响蛋白质的几何形状、静电相互作用、损害蛋白质的ATP/底物结合和激酶活性,从而可能失调蛋白质-蛋白质相互作用并调节各种癌症途径。此外,它在癌症(血液癌、生殖癌和胃肠道癌)中的显著表达,在驱动侵袭/转移中的作用,以及在癌症队列中存在YES1突变谱的证据,加强了本研究的发现。因此,R199H和E290K snp是最可能在癌症患者中筛选的snp,以建立合理的联系,指导精准治疗,对抗耐药,提高临床获益。
{"title":"YES1 c.596C>T (p.Arg199His) and YES1 c.868C>T (p.Glu290Lys) missense polymorphism linked to hematological and reproductive organ cancer: A hidden Markov model (HMM) based approach","authors":"Raushan Kumar Chaudhary ,&nbsp;Allen Pinto ,&nbsp;Niyas Rehman ,&nbsp;Debodipta Das ,&nbsp;Rajesh Raju","doi":"10.1016/j.humgen.2025.201487","DOIUrl":"10.1016/j.humgen.2025.201487","url":null,"abstract":"<div><div><em>YES1</em> is a novel proto-oncogene that has largely gained popularity in oncology over the last few years owing to its pivotal role in tumorigenesis, and drug resistance to various targeted therapy (<em>EGFR, HER2</em>) and cancer chemotherapy, resulting in poor survival outcomes, which has been frequently linked with its amplification rather than the mutation. Thus, this study hypothesizes that cancer development might also be linked with a mutation in <em>YES1,</em> not merely amplification of the gene. In the present study, <em>YES1</em> gene-associated missense SNPs were retrieved from the dbSNP-NCBI database, which were screened for deleterious/damaging and pathogenicity. The pathogenic SNPs were assessed for their stability and potential to cause cancer. The oncogenic SNPs were further evaluated for its location in the domain, conservation, structural effect, and interactions. Further, <em>YES1</em> expression in cancer, its hallmark efficiency and mutation in cancer was assessed to support the study findings. A total of 381 SNPs were identified from dbSNP-NCBI of which 7 SNPs were found to be deleterious, damaging and pathogenic by applying six tools. Out of these 7 SNPs, <em>YES1 c.596C</em> <em>&gt;</em> <em>T (p.Arg199His)</em> and <em>YES1 c.868C</em> <em>&gt;</em> <em>T (p.Glu290Lys)</em> were predicted destabilize the protein and associated with blood cancer, and solid cancer like reproductive organ cancer, and gastrointestinal (GI) cancer respectively. Both these oncogenic SNPs occurs in core biologically active conserved domain (SH2 and tyrosine kinase) of <em>YES1</em> protein thereby influences the protein geometry, electrostatic interaction, impairs the ATP/substrate binding and kinase activity of the protein which might dysregulate the protein-protein interaction and modulate various cancer pathways. Further, its significant expression in cancer (hematologic, reproductive and GI cancer), role in driving invasion/metastasis, and evidence of <em>YES1</em> mutation profile in cancer cohort strengthen the findings of current study. Thus, R199H and E290K SNPs are the most probable SNPs that should be screened among cancer patients to establish a plausible link which can guide towards the precision therapy to counter the drug resistance and enhance the clinical benefit in upcoming years.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201487"},"PeriodicalIF":0.7,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review on the role of miR-576 in human disorders miR-576在人类疾病中的作用研究进展
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-30 DOI: 10.1016/j.humgen.2025.201491
Alireza Soleimani , Mohsen Ahmadi , Mahla Sanati , Hadi Adabi , Soudeh Ghafouri-Fard
MicroRNAs (miRNAs) have pivotal role in post-transcriptional gene regulation by binding to target mRNAs, resulting in their degradation or translational repression. They contribute to the pathogenesis of several disorders, including cancer, autoimmune conditions and metabolic disorders. Among these non-coding transcripts is miR-576, a miRNA with dual roles in tumorigenesis and significant participation in non-malignant conditions. Through modulation of key cellular processes such as proliferation, apoptosis, migration, and immune responses, this miRNA participates in the pathoetiology of a variety of human disorders. This manuscript aims to comprehensively review the current understanding of miR-576 in malignant and non-malignant disorders, emphasizing its mechanistic roles, clinical implications, and therapeutic potential. By integrating the current knowledge on its role, we offer insights into the dual nature of miR-576 in disease pathogenesis and discover future directions for research and therapeutic development.
MicroRNAs (miRNAs)通过与靶mrna结合,导致其降解或翻译抑制,在转录后基因调控中起着关键作用。它们有助于多种疾病的发病机制,包括癌症、自身免疫性疾病和代谢紊乱。在这些非编码转录本中,miR-576是一种在肿瘤发生和非恶性疾病中具有双重作用的miRNA。通过调节关键的细胞过程,如增殖、凋亡、迁移和免疫反应,该miRNA参与了多种人类疾病的病理过程。本文旨在全面回顾目前对miR-576在恶性和非恶性疾病中的认识,强调其机制作用、临床意义和治疗潜力。通过整合目前关于其作用的知识,我们提供了miR-576在疾病发病机制中的双重性质的见解,并发现了未来的研究和治疗发展方向。
{"title":"A review on the role of miR-576 in human disorders","authors":"Alireza Soleimani ,&nbsp;Mohsen Ahmadi ,&nbsp;Mahla Sanati ,&nbsp;Hadi Adabi ,&nbsp;Soudeh Ghafouri-Fard","doi":"10.1016/j.humgen.2025.201491","DOIUrl":"10.1016/j.humgen.2025.201491","url":null,"abstract":"<div><div>MicroRNAs (miRNAs) have pivotal role in post-transcriptional gene regulation by binding to target mRNAs, resulting in their degradation or translational repression. They contribute to the pathogenesis of several disorders, including cancer, autoimmune conditions and metabolic disorders. Among these non-coding transcripts is miR-576, a miRNA with dual roles in tumorigenesis and significant participation in non-malignant conditions. Through modulation of key cellular processes such as proliferation, apoptosis, migration, and immune responses, this miRNA participates in the pathoetiology of a variety of human disorders. This manuscript aims to comprehensively review the current understanding of miR-576 in malignant and non-malignant disorders, emphasizing its mechanistic roles, clinical implications, and therapeutic potential. By integrating the current knowledge on its role, we offer insights into the dual nature of miR-576 in disease pathogenesis and discover future directions for research and therapeutic development.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201491"},"PeriodicalIF":0.7,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated in silico and experimental analysis identifies MAGE-A3, TRIM28, and HLA-A as immunomodulatory targets in lung cancer 集成芯片和实验分析确定MAGE-A3, TRIM28和HLA-A是肺癌的免疫调节靶点
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-30 DOI: 10.1016/j.humgen.2025.201492
Gaurang Telang , Smriti Mishra , Anurag Sureshbabu , Sagar Barage , A.W. Santhosh Kumar , Rajshri Singh
MAGEA3, a cancer-testis antigen selectively expressed in tumors, has been widely explored as a target for cancer immunotherapy, yet its broader immunoregulatory function in the lung tumor microenvironment remains insufficiently characterized. In this study, we conducted an integrative in silico analysis using transcriptomic data from TCGA-LUSC to delineate the expression landscape, immune contexture, and molecular interactions of MAGEA3. Protein–protein interaction networks constructed via STRING and ranked through CytoHubba identified TRIM28 and HLA-A as key co-regulatory molecules, implicating MAGEA3 in transcriptional repression and antigen presentation. TIMER2.0 deconvolution revealed cell-type–specific associations, including differential relationships with CD8+ T cells, dendritic cells, and macrophages. Gene-wise survival modeling in TCGA-LUSC indicated MAGEA3 and MAGEA6 associate with reduced overall survival, whereas TRIM28 showed a borderline protective trend. Experimental validation via RT-qPCR in A549 cells confirmed detectable expression of MAGEA3, TRIM28, and HLA-A, reinforcing the computational predictions and highlighting potential cross-histological relevance. Collectively, these findings position MAGEA3 within immunomodulatory circuits of lung cancer and support its consideration in multimodal immunotherapeutic paradigms.
MAGEA3是一种在肿瘤中选择性表达的癌睾丸抗原,作为癌症免疫治疗的靶点已被广泛探索,但其在肺肿瘤微环境中更广泛的免疫调节功能尚不充分。在这项研究中,我们利用TCGA-LUSC的转录组学数据进行了综合的计算机分析,以描绘MAGEA3的表达格局、免疫环境和分子相互作用。通过STRING构建并通过CytoHubba排序的蛋白-蛋白相互作用网络确定TRIM28和HLA-A为关键的共调控分子,暗示MAGEA3参与转录抑制和抗原提呈。TIMER2.0反褶积揭示了细胞类型特异性关联,包括与CD8+ T细胞、树突状细胞和巨噬细胞的差异关系。TCGA-LUSC的基因生存模型显示,MAGEA3和MAGEA6与总生存降低相关,而TRIM28表现出边缘保护趋势。通过RT-qPCR在A549细胞中进行实验验证,证实了MAGEA3、TRIM28和HLA-A的可检测表达,加强了计算预测并突出了潜在的跨组织相关性。总的来说,这些发现将MAGEA3定位在肺癌的免疫调节回路中,并支持其在多模式免疫治疗范式中的考虑。
{"title":"Integrated in silico and experimental analysis identifies MAGE-A3, TRIM28, and HLA-A as immunomodulatory targets in lung cancer","authors":"Gaurang Telang ,&nbsp;Smriti Mishra ,&nbsp;Anurag Sureshbabu ,&nbsp;Sagar Barage ,&nbsp;A.W. Santhosh Kumar ,&nbsp;Rajshri Singh","doi":"10.1016/j.humgen.2025.201492","DOIUrl":"10.1016/j.humgen.2025.201492","url":null,"abstract":"<div><div>MAGEA3, a cancer-testis antigen selectively expressed in tumors, has been widely explored as a target for cancer immunotherapy, yet its broader immunoregulatory function in the lung tumor microenvironment remains insufficiently characterized. In this study, we conducted an integrative in silico analysis using transcriptomic data from TCGA-LUSC to delineate the expression landscape, immune contexture, and molecular interactions of MAGEA3. Protein–protein interaction networks constructed via STRING and ranked through CytoHubba identified TRIM28 and HLA-A as key co-regulatory molecules, implicating MAGEA3 in transcriptional repression and antigen presentation. TIMER2.0 deconvolution revealed cell-type–specific associations, including differential relationships with CD8<sup>+</sup> T cells, dendritic cells, and macrophages. Gene-wise survival modeling in TCGA-LUSC indicated MAGEA3 and MAGEA6 associate with reduced overall survival, whereas TRIM28 showed a borderline protective trend. Experimental validation via RT-qPCR in A549 cells confirmed detectable expression of MAGEA3, TRIM28, and HLA-A, reinforcing the computational predictions and highlighting potential cross-histological relevance. Collectively, these findings position MAGEA3 within immunomodulatory circuits of lung cancer and support its consideration in multimodal immunotherapeutic paradigms.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201492"},"PeriodicalIF":0.7,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LiqBiMark: An advanced bioinformatics pipeline for integrative transcriptomic analysis and identification of non-invasive prognostic biomarkers using GEO datasets LiqBiMark:一个先进的生物信息学管道,用于整合转录组学分析和使用GEO数据集鉴定非侵入性预后生物标志物
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-29 DOI: 10.1016/j.humgen.2025.201490
Amir Mohammad Mazhari , Farshad Safaei , Mahsa Torkamanian-Afshar , Ali Najafi

Background

The Gene Expression Omnibus (GEO) database was established by the National Center for Biotechnology Information (NCBI) to facilitate sharing molecular biology data. This repository hosts numerous datasets related to complex diseases such as cancer, generated by researchers worldwide. One of the most challenging issues is finding non-invasive biomarkers in the vast amount of data deposited in public databases related to a specific type of cancer.

Results

To address this issue, we have designed a Liquid Biopsy Biomarker Discovery (LiqBiMark) pipeline that compares two datasets on the same type of cancer, but with different sample sources, to propose potential biomarker candidates. Additionally, the LiqBiMark generates co-expression networks and conducts clustering analysis.

Conclusions

The pipeline is designed to be accessible even to users with minimal experience, allowing them to obtain results quickly and efficiently.
GEO (Gene Expression Omnibus)数据库是由美国国家生物技术信息中心(NCBI)为促进分子生物学数据共享而建立的。该存储库拥有由世界各地的研究人员生成的与癌症等复杂疾病相关的大量数据集。最具挑战性的问题之一是在与特定类型癌症相关的公共数据库中存储的大量数据中找到非侵入性生物标志物。为了解决这个问题,我们设计了一个液体活检生物标志物发现(Liquid Biopsy Biomarker Discovery, LiqBiMark)管道,该管道比较了同一类型癌症的两个数据集,但具有不同的样本来源,以提出潜在的生物标志物候选物。此外,LiqBiMark生成共表达网络并进行聚类分析。结论:该管道的设计即使对经验最少的用户也是可访问的,使他们能够快速有效地获得结果。
{"title":"LiqBiMark: An advanced bioinformatics pipeline for integrative transcriptomic analysis and identification of non-invasive prognostic biomarkers using GEO datasets","authors":"Amir Mohammad Mazhari ,&nbsp;Farshad Safaei ,&nbsp;Mahsa Torkamanian-Afshar ,&nbsp;Ali Najafi","doi":"10.1016/j.humgen.2025.201490","DOIUrl":"10.1016/j.humgen.2025.201490","url":null,"abstract":"<div><h3>Background</h3><div>The Gene Expression Omnibus (GEO) database was established by the National Center for Biotechnology Information (NCBI) to facilitate sharing molecular biology data. This repository hosts numerous datasets related to complex diseases such as cancer, generated by researchers worldwide. One of the most challenging issues is finding non-invasive biomarkers in the vast amount of data deposited in public databases related to a specific type of cancer.</div></div><div><h3>Results</h3><div>To address this issue, we have designed a Liquid Biopsy Biomarker Discovery (LiqBiMark) pipeline that compares two datasets on the same type of cancer, but with different sample sources, to propose potential biomarker candidates. Additionally, the LiqBiMark generates co-expression networks and conducts clustering analysis.</div></div><div><h3>Conclusions</h3><div>The pipeline is designed to be accessible even to users with minimal experience, allowing them to obtain results quickly and efficiently.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201490"},"PeriodicalIF":0.7,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145319600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The LEPR gene: A multifaceted regulator of energy homeostasis, obesity pathogenesis, and metabolic health LEPR基因:能量稳态、肥胖发病机制和代谢健康的多方面调节因子
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-25 DOI: 10.1016/j.humgen.2025.201486
Isar Sharma , Nishutosh , Kritika Bakshi , Ritu Mahajan , Nisha Kapoor

Background & Aim

This review examines the leptin-LEPR axis and its role in regulating energy balance and obesity. The LEPR gene provides the essential instructions for synthesizing the leptin receptor, a protein of paramount importance within the neuroendocrine system that orchestrates energy balance. Leptin, an adipokine secreted primarily by adipose tissue, functions as a critical signal reflecting the body's energy stores. It modulates appetite and energy expenditure by binding to its cognate receptor, which is predominantly expressed in the hypothalamus.

Materials & methods

The authors comprehensively examined a wide range of studies to detail the function of the LEPR gene and the complex intracellular signalling pathways it initiates. The focus was on understanding how dysfunctions, from rare genetic mutations to common acquired leptin resistance, disrupt these homeostatic mechanisms.

Results

The review confirms that when leptin binds to its receptor, it initiates a complex cascade of intracellular signalling pathways. These include the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) and phosphatidylinositol 3 kinase (PI3K)/Akt pathways. Dysfunction of the leptin-LEPR axis, whether stemming from rare genetic mutations leading to congenital leptin receptor deficiency or the more prevalent acquired leptin resistance observed in common obesity, severely disrupts these intricate homeostatic mechanisms. Such disruptions invariably manifest as profound hyperphagia (excessive hunger) and severe obesity.

Conclusion

A comprehensive understanding of the LEPR axis and its intricate signalling networks is therefore fundamental for elucidating the pathophysiology of obesity and for the development of effective therapeutic strategies.
背景与目的本文综述了瘦素- lepr轴及其在调节能量平衡和肥胖中的作用。LEPR基因为瘦素受体的合成提供了必要的指令,瘦素受体是神经内分泌系统中最重要的蛋白质,负责协调能量平衡。瘦素是一种主要由脂肪组织分泌的脂肪因子,是反映身体能量储存的关键信号。它通过结合其主要在下丘脑表达的同源受体来调节食欲和能量消耗。材料和方法作者全面检查了广泛的研究,详细介绍了LEPR基因的功能和它所启动的复杂的细胞内信号通路。研究的重点是了解从罕见的基因突变到常见的获得性瘦素抵抗等功能障碍是如何破坏这些体内平衡机制的。结果该综述证实,当瘦素与其受体结合时,它启动了一个复杂的细胞内信号通路级联。其中包括Janus kinase 2 (JAK2)/信号转导和转录激活因子3 (STAT3)和磷脂酰肌醇3激酶(PI3K)/Akt通路。无论是由于罕见的基因突变导致先天性瘦素受体缺乏,还是在常见肥胖中观察到的更普遍的获得性瘦素抵抗,瘦素- lepr轴的功能障碍都严重破坏了这些复杂的体内平衡机制。这种破坏总是表现为严重的贪食(过度饥饿)和严重的肥胖。因此,全面了解LEPR轴及其复杂的信号网络对于阐明肥胖的病理生理和制定有效的治疗策略至关重要。
{"title":"The LEPR gene: A multifaceted regulator of energy homeostasis, obesity pathogenesis, and metabolic health","authors":"Isar Sharma ,&nbsp;Nishutosh ,&nbsp;Kritika Bakshi ,&nbsp;Ritu Mahajan ,&nbsp;Nisha Kapoor","doi":"10.1016/j.humgen.2025.201486","DOIUrl":"10.1016/j.humgen.2025.201486","url":null,"abstract":"<div><h3>Background &amp; Aim</h3><div>This review examines the leptin-LEPR axis and its role in regulating energy balance and obesity. The <em>LEPR</em> gene provides the essential instructions for synthesizing the leptin receptor, a protein of paramount importance within the neuroendocrine system that orchestrates energy balance. Leptin, an adipokine secreted primarily by adipose tissue, functions as a critical signal reflecting the body's energy stores. It modulates appetite and energy expenditure by binding to its cognate receptor, which is predominantly expressed in the hypothalamus.</div></div><div><h3>Materials &amp; methods</h3><div>The authors comprehensively examined a wide range of studies to detail the function of the <em>LEPR</em> gene and the complex intracellular signalling pathways it initiates. The focus was on understanding how dysfunctions, from rare genetic mutations to common acquired leptin resistance, disrupt these homeostatic mechanisms.</div></div><div><h3>Results</h3><div>The review confirms that when leptin binds to its receptor, it initiates a complex cascade of intracellular signalling pathways. These include the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) and phosphatidylinositol 3 kinase (PI3K)/Akt pathways. Dysfunction of the leptin-LEPR axis, whether stemming from rare genetic mutations leading to congenital leptin receptor deficiency or the more prevalent acquired leptin resistance observed in common obesity, severely disrupts these intricate homeostatic mechanisms. Such disruptions invariably manifest as profound hyperphagia (excessive hunger) and severe obesity.</div></div><div><h3>Conclusion</h3><div>A comprehensive understanding of the <em>LEPR</em> axis and its intricate signalling networks is therefore fundamental for elucidating the pathophysiology of obesity and for the development of effective therapeutic strategies.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201486"},"PeriodicalIF":0.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crosstalk between MitomiRs and cardiovascular disease mitomir与心血管疾病之间的串扰
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-25 DOI: 10.1016/j.humgen.2025.201488
Rashi Khare, Nilanjana Ghosh, Sunanda Arya, Swati Srivastava, Iti Garg

Background

Mitochondrial microRNAs (mitomiRs) have emerged as vital regulators in the etiology of cardiovascular disease (CVD). Differential mitomiR expression contributes to mitochondrial dysfunction which is a key contributor to heart failure, ischemia, and cardiomyopathic hypertrophy. Despite advances, the specific downstream pathways and molecular mechanisms influenced by mitomiRs remain inadequately defined. We have investigated mitomiRs which are associated with CVD.

Methods

A systematic literature review was conducted using PubMed to identify mitomiRs associated with cardiovascular disease. Experimentally validated target gene interactions were analyzed using MiRDB and MirTarBase. Protein-protein interaction (PPI) networks were constructed with STRING, and functional enrichment analyses, including Gene Ontology (GO) and KEGG pathway analyses, were performed using an SR plot. Hub gene identification was executed via the CytoHubba plugin in Cytoscape, pinpointing key regulatory nodes within the network.

Results

The present study identified 21 mitomiRs that modulate the coagulation gene pathway in cardiovascular disease. Notably, the amyloid precursor protein (APP) was recognized as a central hub. APP acts as a crucial intersection between the regulation of coagulation and mitochondrial protein clusters. Among the top 15 hub genes, APP was highlighted as a significant molecular regulator that potentially linked mitochondrial dysfunction with cardiovascular pathology.

Conclusion

Mitomir plays a critical role in the regulation of mitochondrial function in various cardiovascular diseases. Mitomir not only regulates the mitochondrial function but also are involved in the coagulation pathway. Mitochondrial dysfunction may have been a result of the involvement of amyloid precursor protein which itself is the main regulator of Alzheimer's disease. Hence uncovering the potential role behind APP in cardiovascular disease may help to unlock a potential target that is still missing in CVD.
线粒体microRNAs (mitomiRs)已成为心血管疾病(CVD)病因学中的重要调节因子。mitomiR的差异表达导致线粒体功能障碍,而线粒体功能障碍是心力衰竭、缺血和心肌病性肥厚的关键因素。尽管取得了进展,但受mitomir影响的特定下游途径和分子机制仍然不充分确定。我们研究了与心血管疾病相关的mitomir。方法利用PubMed进行系统文献综述,确定与心血管疾病相关的mitomir。实验验证的靶基因相互作用分析使用MiRDB和MirTarBase。使用STRING构建蛋白-蛋白相互作用(PPI)网络,并使用SR图进行功能富集分析,包括基因本体(GO)和KEGG通路分析。Hub基因鉴定是通过Cytoscape中的CytoHubba插件执行的,确定了网络中的关键调控节点。结果本研究鉴定了21个调节心血管疾病凝血基因通路的mitomir。值得注意的是,淀粉样前体蛋白(APP)被认为是一个中心枢纽。APP在凝血调节和线粒体蛋白簇之间起着至关重要的交叉作用。在前15个中心基因中,APP被强调为一个重要的分子调节因子,可能将线粒体功能障碍与心血管病理联系起来。结论mitomir在多种心血管疾病的线粒体功能调控中起重要作用。Mitomir不仅调节线粒体功能,还参与凝血途径。线粒体功能障碍可能是淀粉样蛋白前体蛋白参与的结果,淀粉样蛋白本身就是阿尔茨海默病的主要调节因子。因此,揭示APP在心血管疾病中的潜在作用可能有助于解开CVD中仍然缺失的潜在靶标。
{"title":"Crosstalk between MitomiRs and cardiovascular disease","authors":"Rashi Khare,&nbsp;Nilanjana Ghosh,&nbsp;Sunanda Arya,&nbsp;Swati Srivastava,&nbsp;Iti Garg","doi":"10.1016/j.humgen.2025.201488","DOIUrl":"10.1016/j.humgen.2025.201488","url":null,"abstract":"<div><h3>Background</h3><div>Mitochondrial microRNAs (mitomiRs) have emerged as vital regulators in the etiology of cardiovascular disease (CVD). Differential mitomiR expression contributes to mitochondrial dysfunction which is a key contributor to heart failure, ischemia, and cardiomyopathic hypertrophy. Despite advances, the specific downstream pathways and molecular mechanisms influenced by mitomiRs remain inadequately defined. We have investigated mitomiRs which are associated with CVD.</div></div><div><h3>Methods</h3><div>A systematic literature review was conducted using PubMed to identify mitomiRs associated with cardiovascular disease. Experimentally validated target gene interactions were analyzed using MiRDB and MirTarBase. Protein-protein interaction (PPI) networks were constructed with STRING, and functional enrichment analyses, including Gene Ontology (GO) and KEGG pathway analyses, were performed using an SR plot. Hub gene identification was executed via the CytoHubba plugin in Cytoscape, pinpointing key regulatory nodes within the network.</div></div><div><h3>Results</h3><div>The present study identified 21 mitomiRs that modulate the coagulation gene pathway in cardiovascular disease. Notably, the amyloid precursor protein (APP) was recognized as a central hub. APP acts as a crucial intersection between the regulation of coagulation and mitochondrial protein clusters. Among the top 15 hub genes, APP was highlighted as a significant molecular regulator that potentially linked mitochondrial dysfunction with cardiovascular pathology.</div></div><div><h3>Conclusion</h3><div>Mitomir plays a critical role in the regulation of mitochondrial function in various cardiovascular diseases. Mitomir not only regulates the mitochondrial function but also are involved in the coagulation pathway. Mitochondrial dysfunction may have been a result of the involvement of amyloid precursor protein which itself is the main regulator of Alzheimer's disease. Hence uncovering the potential role behind APP in cardiovascular disease may help to unlock a potential target that is still missing in CVD.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201488"},"PeriodicalIF":0.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of TBXA2R, TGF-β1 and Il-18 gene polymorphisms in the pathogenesis of pollen induced allergic asthma- a case-control study from West Bengal, India TBXA2R、TGF-β1和Il-18基因多态性在花粉诱导过敏性哮喘发病机制中的作用——来自印度西孟加拉邦的病例对照研究
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-23 DOI: 10.1016/j.humgen.2025.201485
Priti Mondal , Indranil Ganai , Himani Biswas , Saibal Moitra , Sanjoy Podder

Background

Allergic asthma is a chronic inflammatory disease of the respiratory system's conducting airways affecting 330 million people globally and causes intermittent attacks of breathlessness, wheezing, airway hyper-reactivity and coughing when exposed to specific allergens. Thromboxane A2 receptor (TBXA2R), Transforming Growth Factor Beta 1 (TGF-β1) and Interleukin-18 (IL-18) genes are reported to be involved in inflammatory and immune response pathways related to asthma. Based on the above facts it can be hypothesized that single nucleotide polymorphisms (SNPs) in these genes may be associated with the asthma phenotype.

Objectives

The present study aims to analyze the role of the TBXA2R rs4523, TGF-β1 rs1800470, IL-18 rs1946519, IL-18 rs1946518 and IL-18 rs549908 gene polymorphism in asthma susceptibility among the population of West Bengal, India.

Results

Maximum number of patients showed sensitivity towards Azadirachta indica (73.46 %), followed by Cocos nucifera (72.27 %), Caesalpinia pulcherrima (65.17 %), etc. Significant difference in genotype and allele frequencies was obtained between the study groups for TBXA2R rs4523 and IL-18 rs1946519 polymorphisms. Asthma patients possessed significantly higher frequency of TBXA2R rs4523 CC and IL-18 rs1946519 TT genotypes than controls. TBXA2R rs4523 CC and IL-18 rs1946519 TT genotype bearing patients showed highest intensity of SPT reactions. Patients bearing rs4523 CC and rs1946519 TT genotypes had significantly higher FEV1/FVC ratio, total IgE level and blood Eosinophil count than heterozygous or major genotype bearers.

Conclusion

The present study concluded that TBXA2R rs4523 and IL-18 rs1946519 polymorphisms are associated with allergic asthma susceptibility in the population of West Bengal, India.
过敏性哮喘是一种影响全球3.3亿人的呼吸系统传导气道的慢性炎症性疾病,当暴露于特定过敏原时,会导致间歇性呼吸困难、喘息、气道高反应性和咳嗽。据报道,血栓素A2受体(TBXA2R)、转化生长因子β1 (TGF-β1)和白细胞介素-18 (IL-18)基因参与哮喘相关的炎症和免疫反应途径。基于上述事实,可以假设这些基因的单核苷酸多态性(snp)可能与哮喘表型有关。目的分析TBXA2R rs4523、TGF-β1 rs1800470、IL-18 rs1946519、IL-18 rs1946518和IL-18 rss549908基因多态性在印度西孟加拉邦人群哮喘易感性中的作用。结果对印楝敏感的患者最多(73.46%),其次是椰子树(72.27%)、斑纹麻(65.17%)等。TBXA2R rs4523和IL-18 rs1946519多态性的基因型和等位基因频率在研究组之间存在显著差异。哮喘患者TBXA2R rs4523 CC和IL-18 rs1946519 TT基因型的频率明显高于对照组。携带TBXA2R rs4523 CC和IL-18 rs1946519 TT基因型的患者SPT反应强度最高。携带rs4523 CC和rs1946519 TT基因型的患者FEV1/FVC比值、总IgE水平和血嗜酸性粒细胞计数明显高于杂合子或主要基因型携带者。结论TBXA2R rs4523和IL-18 rs1946519多态性与印度西孟加拉邦人群变应性哮喘易感性相关。
{"title":"The role of TBXA2R, TGF-β1 and Il-18 gene polymorphisms in the pathogenesis of pollen induced allergic asthma- a case-control study from West Bengal, India","authors":"Priti Mondal ,&nbsp;Indranil Ganai ,&nbsp;Himani Biswas ,&nbsp;Saibal Moitra ,&nbsp;Sanjoy Podder","doi":"10.1016/j.humgen.2025.201485","DOIUrl":"10.1016/j.humgen.2025.201485","url":null,"abstract":"<div><h3>Background</h3><div>Allergic asthma is a chronic inflammatory disease of the respiratory system's conducting airways affecting 330 million people globally and causes intermittent attacks of breathlessness, wheezing, airway hyper-reactivity and coughing when exposed to specific allergens. Thromboxane A2 receptor (TBXA2R), Transforming Growth Factor Beta 1 (TGF-β1) and Interleukin-18 (IL-18) genes are reported to be involved in inflammatory and immune response pathways related to asthma. Based on the above facts it can be hypothesized that single nucleotide polymorphisms (SNPs) in these genes may be associated with the asthma phenotype.</div></div><div><h3>Objectives</h3><div>The present study aims to analyze the role of the TBXA2R rs4523, TGF-β1 rs1800470, IL-18 rs1946519, IL-18 rs1946518 and IL-18 rs549908 gene polymorphism in asthma susceptibility among the population of West Bengal, India.</div></div><div><h3>Results</h3><div>Maximum number of patients showed sensitivity towards <em>Azadirachta indica</em> (73.46 %), followed by <em>Cocos nucifera</em> (72.27 %), <em>Caesalpinia pulcherrima</em> (65.17 %), etc. Significant difference in genotype and allele frequencies was obtained between the study groups for TBXA2R rs4523 and IL-18 rs1946519 polymorphisms. Asthma patients possessed significantly higher frequency of TBXA2R rs4523 CC and IL-18 rs1946519 TT genotypes than controls. TBXA2R rs4523 CC and IL-18 rs1946519 TT genotype bearing patients showed highest intensity of SPT reactions. Patients bearing rs4523 CC and rs1946519 TT genotypes had significantly higher FEV1/FVC ratio, total IgE level and blood Eosinophil count than heterozygous or major genotype bearers.</div></div><div><h3>Conclusion</h3><div>The present study concluded that TBXA2R rs4523 and IL-18 rs1946519 polymorphisms are associated with allergic asthma susceptibility in the population of West Bengal, India.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201485"},"PeriodicalIF":0.7,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the risk of missense mutation rs137854486 (W1925R) of FN1 in papillary thyroid cancer: A computational and molecular dynamics approach 解读乳头状甲状腺癌中FN1错义突变rs137854486 (W1925R)的风险:计算和分子动力学方法
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-22 DOI: 10.1016/j.humgen.2025.201484
Febby Payva , Remya James , Amrisa Pavithra E. , Padmashree Das , Santhy K.S.
Papillary thyroid cancer (PTC) accounts for more than 85 % of all thyroid cancers. Three transcriptomic datasets of PTC, one each from humans (GSE138198), transgenic mice (GSE58689), and cell lines (GSE6339), were analysed for differentially expressed genes (DEGs). Seventy-three common DEGs were binned into significant pathways associated with cancer and immunity, for which gene ontology studies at the biological process, molecular function, and cellular component levels were performed. Protein–protein interaction (PPI) network construction and analysis of modules identified fibronectin 1 (FN1) as the critical hub gene in the pathophysiology of PTC. Survival analysis, immune infiltration analysis, and co-expression analysis of the hub genes were conducted to confirm their relationship with PTC prognosis. Analysis of four missense variants V692E, T817A, T817P and W1925R of FN1 associated with PTC, followed by structural analysis and molecular dynamics simulation, validated that the missense mutation rs137854486 (W1925R) of FN1 is significant in the tumorigenesis of PTC. FoldX predicted a significant positive ΔΔG (9.85646) value for W1925R, portraying substantial destabilization of FN1. The root mean square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (Rg) values of the W1925R mutant indicate significant structural deviations in the protein, resulting in increased flexibility and reduced stability. Increased flexibility, particularly in regions critical for protein function, could affect the biological activity of the protein, with a crucial influence on the pathophysiology of PTC.
乳头状甲状腺癌(PTC)占所有甲状腺癌的85%以上。分别来自人(GSE138198)、转基因小鼠(GSE58689)和细胞系(GSE6339)的3个PTC转录组学数据集分析差异表达基因(DEGs)。73个常见的deg被归类为与癌症和免疫相关的重要途径,并在生物过程、分子功能和细胞成分水平上进行了基因本体论研究。蛋白-蛋白相互作用(Protein-protein interaction, PPI)网络构建及模块分析表明,纤连蛋白1 (fibronectin, FN1)是PTC病理生理中的关键枢纽基因。通过生存分析、免疫浸润分析和枢纽基因共表达分析,证实其与PTC预后的关系。对与PTC相关的FN1的4个错义变异V692E、T817A、T817P和W1925R进行分析,并进行结构分析和分子动力学模拟,验证了FN1的错义突变rs137854486 (W1925R)在PTC的肿瘤发生中具有重要意义。FoldX预测W1925R的显著阳性ΔΔG(9.85646)值,描绘了FN1的大量不稳定。W1925R突变体的均方根偏差(RMSD)、均方根波动(RMSF)和旋转半径(Rg)值表明,该蛋白存在明显的结构偏差,导致柔韧性增加,稳定性降低。灵活性的增加,特别是在蛋白质功能的关键区域,可能影响蛋白质的生物活性,对PTC的病理生理有重要影响。
{"title":"Deciphering the risk of missense mutation rs137854486 (W1925R) of FN1 in papillary thyroid cancer: A computational and molecular dynamics approach","authors":"Febby Payva ,&nbsp;Remya James ,&nbsp;Amrisa Pavithra E. ,&nbsp;Padmashree Das ,&nbsp;Santhy K.S.","doi":"10.1016/j.humgen.2025.201484","DOIUrl":"10.1016/j.humgen.2025.201484","url":null,"abstract":"<div><div>Papillary thyroid cancer (PTC) accounts for more than 85 % of all thyroid cancers. Three transcriptomic datasets of PTC, one each from humans (GSE138198), transgenic mice (GSE58689), and cell lines (GSE6339), were analysed for differentially expressed genes (DEGs). Seventy-three common DEGs were binned into significant pathways associated with cancer and immunity, for which gene ontology studies at the biological process, molecular function, and cellular component levels were performed. Protein–protein interaction (PPI) network construction and analysis of modules identified fibronectin 1 (FN1) as the critical hub gene in the pathophysiology of PTC. Survival analysis, immune infiltration analysis, and co-expression analysis of the hub genes were conducted to confirm their relationship with PTC prognosis. Analysis of four missense variants V692E, T817A, T817P and W1925R of FN1 associated with PTC, followed by structural analysis and molecular dynamics simulation, validated that the missense mutation rs137854486 (W1925R) of FN1 is significant in the tumorigenesis of PTC. FoldX predicted a significant positive ΔΔG (9.85646) value for W1925R, portraying substantial destabilization of FN1. The root mean square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (Rg) values of the W1925R mutant indicate significant structural deviations in the protein, resulting in increased flexibility and reduced stability. Increased flexibility, particularly in regions critical for protein function, could affect the biological activity of the protein, with a crucial influence on the pathophysiology of PTC.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201484"},"PeriodicalIF":0.7,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the frequency of Dectin-1 rs3901533 A > C and rs7309123 G > C gene variants in patients with acute myeloid leukemia (AML): A case-control study 急性髓性白血病(AML)患者Dectin-1 rs3901533 A > C和rs7309123 G > C基因变异频率的评估:一项病例对照研究
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-22 DOI: 10.1016/j.humgen.2025.201482
Davood Alinezhad Dezfuli , Ehsan Sarbazjoda , Nasrin Amirrajab , Tina Vosoughi , Alireza Momeni , Mohammad Ali Jalali Far

Background

Acute myeloid leukemia (AML) is a serious blood cancer mainly affecting adults, and its predisposing genetic factors remain unclear. While recent studies have linked dectin-1 polymorphisms to fungal infection risk in AML, their relationship with AML susceptibility has not been studied. This study evaluates the association between two dectin-1 single-nucleotide polymorphisms (SNPs) of rs3901533 A > C and rs7309123 G > C and AML risk.

Methods & materials

A total of 103 participants (53 AML patients and 50 age- and sex-matched healthy controls) from the Iranian population were included in this study. Both of the polymorphisms were genotyped using the tetra-ARMS-PCR method.

Results

The genotype distributions of rs3901533 A > C and rs7309123 G > C polymorphisms did not differ significantly between AML patients and controls under additive, dominant, or recessive genetic models (p-value > 0.05). Furthermore, allele frequencies for both SNPs showed no significant association with AML risk (p-value > 0.05). None of the genotypes or alleles increased the risk of AML (p-value > 0.05).

Conclusions

Neither the rs3901533 A > C nor the rs7309123 G > C polymorphisms are contributors to increased susceptibility to AML. However, further investigations are needed.
急性髓系白血病(acute myeloid leukemia, AML)是一种主要影响成人的严重血癌,其易感遗传因素尚不清楚。虽然最近的研究将dectin-1多态性与AML真菌感染风险联系起来,但它们与AML易感性的关系尚未研究。本研究评估了rs3901533 A >; C和rs7309123 G >; C的两个检测素-1单核苷酸多态性(snp)与AML风险之间的关系。方法材料本研究共纳入103名伊朗人群参与者(53名AML患者和50名年龄和性别匹配的健康对照)。两种多态性均采用4 - arms - pcr方法进行基因分型。结果rs3901533 A >; C和rs7309123 G >; C在加性、显性和隐性遗传模型下的基因型分布在AML患者和对照组之间无显著差异(p值>; 0.05)。此外,两种snp的等位基因频率与AML风险无显著关联(p值>; 0.05)。所有基因型或等位基因均未增加AML的风险(p值>; 0.05)。结论rs3901533 A >; C和rs7309123 G >; C多态性都不是AML易感性增加的因素。然而,还需要进一步的调查。
{"title":"Evaluation of the frequency of Dectin-1 rs3901533 A > C and rs7309123 G > C gene variants in patients with acute myeloid leukemia (AML): A case-control study","authors":"Davood Alinezhad Dezfuli ,&nbsp;Ehsan Sarbazjoda ,&nbsp;Nasrin Amirrajab ,&nbsp;Tina Vosoughi ,&nbsp;Alireza Momeni ,&nbsp;Mohammad Ali Jalali Far","doi":"10.1016/j.humgen.2025.201482","DOIUrl":"10.1016/j.humgen.2025.201482","url":null,"abstract":"<div><h3>Background</h3><div>Acute myeloid leukemia (AML) is a serious blood cancer mainly affecting adults, and its predisposing genetic factors remain unclear. While recent studies have linked dectin-1 polymorphisms to fungal infection risk in AML, their relationship with AML susceptibility has not been studied. This study evaluates the association between two dectin-1 single-nucleotide polymorphisms (SNPs) of rs3901533 A &gt; C and rs7309123 G &gt; C and AML risk.</div></div><div><h3>Methods &amp; materials</h3><div>A total of 103 participants (53 AML patients and 50 age- and sex-matched healthy controls) from the Iranian population were included in this study. Both of the polymorphisms were genotyped using the tetra-ARMS-PCR method.</div></div><div><h3>Results</h3><div>The genotype distributions of rs3901533 A &gt; C and rs7309123 G &gt; C polymorphisms did not differ significantly between AML patients and controls under additive, dominant, or recessive genetic models (<em>p-value</em> &gt; 0.05). Furthermore, allele frequencies for both SNPs showed no significant association with AML risk (<em>p-value</em> &gt; 0.05). None of the genotypes or alleles increased the risk of AML (<em>p-value</em> &gt; 0.05).</div></div><div><h3>Conclusions</h3><div>Neither the rs3901533 A &gt; C nor the rs7309123 G &gt; C polymorphisms are contributors to increased susceptibility to AML. However, further investigations are needed.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201482"},"PeriodicalIF":0.7,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-onset nephrolithiasis and persistent microscopic hematuria in a child with a novel pathogenic COL4A5 variant in Alport syndrome: A case report and literature review 早发性肾结石和持续性显微镜下血尿在儿童与新的致病性COL4A5变异在Alport综合征:1例报告和文献复习
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2025-09-19 DOI: 10.1016/j.humgen.2025.201483
Firoz Ahmad , Niladri Bose , Alec Correa , Sapna Sandal , Mukesh Kumar , Akashi Vyas , Amisha Shah , Meenu Angi , Jigar Suthar , Pooja Chaudhary , Anindyajit Banerjee , Spandan Chaudhary , Neeraj Arora
A 4-year-old male with persistent microscopic hematuria, hypocalciuria along with hypocitraturia. Renal ultrasound revealed bilateral microcalculi without structural anomalies. Ophthalmic and auditory evaluations were unremarkable. Family history indicated renal disease in the maternal aunt and maternal microscopic hematuria. Whole-exome sequencing (WES) identified a novel hemizygous nonsense variant in COL4A5 (NM_033380.3: c.1555C > T; p.Gln519*), truncating the protein at codon 519 of 1770. The variant, inherited from the mildly symptomatic mother (microscopic hematuria, right renal cyst), was absent in population databases and classified as pathogenic based on ACMG criteria (PVS1_Strong, PM2_Supporting, PP1_Supporting, PP4_Supporting). CytoScan 750 K array ruled out copy-number variations. This case expands the genotypic spectrum of Alport syndrome (AS), demonstrating an early presentation with nephrolithiasis, and underscores the diagnostic utility of WES in atypical inherited nephropathies.
1例4岁男性,镜下持续性血尿,低钙尿伴低尿。肾超声示双侧微结石,无结构异常。眼科和听觉评价无显著差异。家族史提示姨妈有肾脏疾病,母亲镜下血尿。全外显子组测序(WES)在COL4A5中发现了一个新的半合子无义变异(NM_033380.3: c.1555C >; T; p.Gln519*),截断了1770密码子519处的蛋白。该变异遗传自轻度症状的母亲(显微镜下血尿,右肾囊肿),在人群数据库中缺失,并根据ACMG标准(PVS1_Strong, pm2_support, pp1_support, pp4_support)分类为致病性。CytoScan 750 K阵列排除了拷贝数变化。本病例扩展了Alport综合征(AS)的基因型谱,显示了肾结石的早期表现,并强调了WES在非典型遗传性肾病中的诊断价值。
{"title":"Early-onset nephrolithiasis and persistent microscopic hematuria in a child with a novel pathogenic COL4A5 variant in Alport syndrome: A case report and literature review","authors":"Firoz Ahmad ,&nbsp;Niladri Bose ,&nbsp;Alec Correa ,&nbsp;Sapna Sandal ,&nbsp;Mukesh Kumar ,&nbsp;Akashi Vyas ,&nbsp;Amisha Shah ,&nbsp;Meenu Angi ,&nbsp;Jigar Suthar ,&nbsp;Pooja Chaudhary ,&nbsp;Anindyajit Banerjee ,&nbsp;Spandan Chaudhary ,&nbsp;Neeraj Arora","doi":"10.1016/j.humgen.2025.201483","DOIUrl":"10.1016/j.humgen.2025.201483","url":null,"abstract":"<div><div>A 4-year-old male with persistent microscopic hematuria, hypocalciuria along with hypocitraturia. Renal ultrasound revealed bilateral microcalculi without structural anomalies. Ophthalmic and auditory evaluations were unremarkable. Family history indicated renal disease in the maternal aunt and maternal microscopic hematuria. Whole-exome sequencing (WES) identified a novel hemizygous nonsense variant in <em>COL4A5</em> (NM_033380.3: c.1555C &gt; T; p.Gln519*), truncating the protein at codon 519 of 1770. The variant, inherited from the mildly symptomatic mother (microscopic hematuria, right renal cyst), was absent in population databases and classified as pathogenic based on ACMG criteria (PVS1_Strong, PM2_Supporting, PP1_Supporting, PP4_Supporting). CytoScan 750 K array ruled out copy-number variations. This case expands the genotypic spectrum of Alport syndrome (AS), demonstrating an early presentation with nephrolithiasis, and underscores the diagnostic utility of WES in atypical inherited nephropathies.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"46 ","pages":"Article 201483"},"PeriodicalIF":0.7,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Human Gene
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1